These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12792506)

  • 1. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation.
    Tzakis AG; Kato T; Nishida S; Levi DM; Tryphonopoulos P; Madariaga JR; De Faria W; Nery JR; Regev A; Vianna R; Miller J; Esquenazi V; Weppler D; Ruiz P
    Transplantation; 2003 May; 75(9):1512-7. PubMed ID: 12792506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.
    Tzakis AG; Kato T; Nishida S; Levi DM; Madariaga JR; Nery JR; Mittal N; Regev A; Cantwell P; Gyamfi A; Weppler D; Miller J; Tryphonopoulos P; Ruiz P
    Transplantation; 2003 Apr; 75(8):1227-31. PubMed ID: 12717207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
    Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation.
    Tzakis AG; Tryphonopoulos P; Kato T; Nishida S; Levi DM; Madariaga JR; Gaynor JJ; De Faria W; Regev A; Esquenazi V; Weppler D; Ruiz P; Miller J
    Transplantation; 2004 Apr; 77(8):1209-14. PubMed ID: 15114087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China.
    Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L
    Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients.
    Nishida S; Levi DM; Moon JI; Madariaga JR; Kato T; Selvaggi G; Tryphonopoulos P; DeFaria W; Santiago S; Gaynor J; Weppler D; Martinez E; Ruiz P; Tzakis AG
    Transplant Proc; 2006; 38(6):1747-9. PubMed ID: 16908270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.
    Lauro A; Amaduzzi A; Dazzi A; Ercolani G; Zanfi C; Golfieri L; Grazi GL; Vivarelli M; Cescon M; Varotti G; Del Gaudio M; Ravaioli M; Siniscalchi A; Faenza S; D'Errico A; Di Simone M; Pironi L; Pinna AD
    Dig Liver Dis; 2007 Mar; 39(3):253-6. PubMed ID: 17275428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression.
    Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S
    Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapy for acute rejection in intestinal transplantation.
    Pascher A; Klupp J; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 Apr; 37(3):1635-6. PubMed ID: 15866693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
    Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
    Garcia M; Weppler D; Mittal N; Nishida S; Kato T; Tzakis A; Ruiz P
    Transplant Proc; 2004 Mar; 36(2):323-4. PubMed ID: 15050146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of acute cellular rejection after renal transplantation with Campath-1H.
    Basu A; Ramkumar M; Tan HP; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
    Transplant Proc; 2005 Mar; 37(2):923-6. PubMed ID: 15848576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.
    Thai NL; Blisard D; Tom K; Basu A; Smetanka C; Tan H; Bentlejewski C; Glidewell J; Britz J; Kowalski R; Shapiro R; Fung J; Marcos A; Zeevi A
    Transplantation; 2006 Dec; 82(12):1649-52. PubMed ID: 17198253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
    Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
    Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Campath 1H induction in adult liver allotransplantation.
    Tryphonopoulos P; Madariaga JR; Kato T; Nishida S; Levi DM; Moon J; Selvaggi G; De Faria W; Regev A; Bejarano P; Khaled A; Safdar K; Esquenazi V; Weppler D; Yoshida H; Ruiz P; Miller J; Tzakis AG
    Transplant Proc; 2005 Mar; 37(2):1203-4. PubMed ID: 15848669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.
    Wu T; Bond G; Martin D; Nalesnik MA; Demetris AJ; Abu-Elmagd K
    Am J Gastroenterol; 2006 Jul; 101(7):1617-24. PubMed ID: 16863569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
    Villanueva ME; Muñoz AS; Casasola CC; Africa JB; Danguilan RA; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2222-5. PubMed ID: 18790198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intestinal and multivisceral transplantation in adult patients: Italian experience.
    Lauro A; Dazzi A; Ercolani G; Cescon M; D'Errico A; Di Simone M; Grazi GL; Vivarelli M; Varotti G; De Ruvo N; Masetti M; Cautero N; Di Benedetto F; Siniscalchi A; Begliomini B; Lazzarotto T; Faenza S; Pironi L; Pinna AD
    Transplant Proc; 2006; 38(6):1696-8. PubMed ID: 16908252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.